Cellcept and Nicotine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Nicotine (nicotine). Common drug interactions include nausea among females and anaemia among males.
The phase IV clinical study analyzes what interactions people have when they take Cellcept and Nicotine. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Cellcept?
Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.
What is Nicotine?
Nicotine has active ingredients of nicotine. It is often used in quit smoking. eHealthMe is studying from 20,443 Nicotine users. Check the latest studies of Nicotine.
13 people who take Cellcept and Nicotine together, and have interactions are studied.

What are the common drug interactions of Cellcept and Nicotine, by gender? *:
female:
- Nausea (feeling of having an urge to vomit)
- Abdominal pain upper
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Drug ineffective
- Frequent bowel movements
- Proctitis ulcerative (inflammation of the rectum and anus ulcerative)
- Abdominal distension
- Abdominal pain
- Back pain
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
male:
- Anaemia (lack of blood)
- Gastroenteritis escherichia coli (inflammation of stomach and intestine caused by escherichia coli infection)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Psychotic disorder
- Renal failure (kidney dysfunction)
- Screaming (a long loud piercing cry)
- Haemolytic uraemic syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more)
- Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
- Aggression
- Chronic kidney disease
What are the common drug interactions of Cellcept and Nicotine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Chronic kidney disease
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
20-29:
n/a
30-39:
n/a
40-49:
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Pneumonitis (inflammation of the walls of the alveoli in the lungs)
- Pulmonary alveolar haemorrhage (acute bleeding)
50-59:
- Anaemia (lack of blood)
- Gastroenteritis escherichia coli (inflammation of stomach and intestine caused by escherichia coli infection)
- Haemolytic uraemic syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more)
- Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
- Abdominal distension
- Abdominal pain
- Back pain
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Ileus (a painful obstruction of the ileum or other part of the intestine)
- Pyrexia (fever)
60+:
- Aggression
- Chest pain
- Hallucination (an experience involving the perception of something not present)
- Immunosuppression
- Insomnia (sleeplessness)
- Lung adenocarcinoma (a form of non-small cell lung cancer)
- Nausea (feeling of having an urge to vomit)
- Peripheral swelling
- Pneumonia
- Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
What are the existing conditions these people have? *
- Pain: 4 people, 30.77%
- Hepatitis C: 3 people, 23.08%
- Sleep Disorder: 2 people, 15.38%
- Nicotine Dependence: 2 people, 15.38%
- Transplant Rejection (a transplant material is not worked): 1 person, 7.69%
- High Blood Pressure: 1 person, 7.69%
- Cardiac Disorder: 1 person, 7.69%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.69%
- Constipation: 1 person, 7.69%
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Cellcept and Nicotine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Cellcept and Nicotine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cellcept:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Nicotine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cellcept and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nicotine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on mycophenolate mofetil and nicotine (the active ingredients of Cellcept and Nicotine, respectively), and Cellcept and Nicotine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Sinemet Cr and Zopiclone - 2 seconds ago
- Could Azathioprine cause Intestinal Stenosis? - 5 seconds ago
- Drug interactions of Alavert and Biotin - 9 seconds ago
- Could Avapro cause Back Pain? - 11 seconds ago
- Drug interactions of Simethicone and Prochlorperazine - 11 seconds ago
- Osteoporosis and International Normalised Ratio Abnormal - 35 seconds ago
- Could Colace cause Myelodysplastic Syndrome? - 35 seconds ago
- Osteoporosis Post-Menopausal and Spinal Osteoarthritis - 41 seconds ago
- Drug interactions of Silodosin and Rosuvastatin Calcium - 43 seconds ago
- Could Lipitor cause Neuroleptic Malignant Syndrome? - 44 seconds ago